Financhill
Back

Sage Therapeutics Quote, Financials, Valuation and Earnings

Sage Therapeutics Price Quote

$5.61

Sage Therapeutics Key Stats

Sell
34
Sage Therapeutics (SAGE) is a Sell

Day range:
$4.95 - $5.62
52-week range:
$4.62 - $28.26
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.19
P/B ratio:
0.62%

Volume:
4.3M
Avg. volume:
1.1M
1-year change:
-73.13%
Market cap:
$343.2M
Revenue:
$86.5M
EPS:
$-5.57

How Much Does Sage Therapeutics Make?

Data Unavailable

Is Sage Therapeutics Growing As A Company?

Data Unavailable

Sage Therapeutics Stock Price Performance

What Is Sage Therapeutics 52-Week High & Low?

Sage Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Sage Therapeutics?

Data Unavailable

Is Sage Therapeutics Cash Flow Positive?

Data Unavailable

Sage Therapeutics Return On Invested Capital

Data Unavailable

Sage Therapeutics Earnings Date & Stock Price

Sage Therapeutics Competitors

  • Who Are Sage Therapeutics's Competitors?
    Below is a list of companies who compete with Sage Therapeutics or are related in some way:
    • Biogen Inc (BIIB)
    • Johnson & Johnson (JNJ)
    • Lifecore Biomedical Inc (LFCR)
    • Outset Medical Inc (OM)
    • Poseida Therapeutics Inc (PSTX)

Sage Therapeutics Dividend Yield

Data Unavailable

Sage Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 1.32%
Revenue: 337.08% 9.37%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 16
Sell Recommendations: 0
Price Target: 24.39
Upside from Last Price: 334.74%

Major Shareholders

Data Unavailable